Chongqing Chemical Industry Vocational College, Changshou, 401220 Chongqing, China.
Comput Math Methods Med. 2022 Mar 17;2022:3989770. doi: 10.1155/2022/3989770. eCollection 2022.
Parkinson's disease is a degenerative disease of the nervous system, which is more common in middle-aged and elderly people. Currently, the incidence of PD is increasing. The disease is a degenerative disease, which is irreversible and requires life-long treatment. Ropinirole hydrochloride can also be used for Parkinson's disease. Therefore, this article conducted research on this; the purpose is to further determine whether the drug can be used for Parkinson's disease. The method used in this article is a method of quantitative analysis and experimental testing. This article selects Parkinson's disease patients from the provincial hospital to conduct investigations and group experiments on these people to test the effects of different levels of ropinirole hydrochloride in the treatment of Parkinson's disease. Experimental data showed that when the dose of ropinirole was 1 mg, its peak concentration reached 24.95 and the clearance rate reached 143.42. This shows that, in the early stage of medication, it has certain benefits in disease control.
帕金森病是一种神经系统退行性疾病，多见于中老年人。目前 PD 的发病率呈上升趋势。该疾病是一种退行性疾病，不可逆转，需要终身治疗。盐酸罗匹尼罗也可用于治疗帕金森病。因此，本文对此进行了研究；目的是进一步确定该药物是否可用于帕金森病。本文采用的方法是定量分析和实验测试的方法。本文从省医院选取帕金森病患者，对这些人进行调查和分组实验，以测试不同水平的盐酸罗匹尼罗在帕金森病治疗中的效果。实验数据表明，当罗匹尼罗的剂量为 1mg 时，其峰浓度达到 24.95，清除率达到 143.42。这表明，在早期用药阶段，它在控制疾病方面具有一定的益处。
